학술논문
Helicobacter pylorieradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial
Document Type
Article
Author
Hawkey, Chris; Avery, Anthony; Coupland, Carol A C; Crooks, Colin; Dumbleton, Jennifer; Hobbs, F D Richard; Kendrick, Denise; Moore, Michael; Morris, Clive; Rubin, Gregory; Smith, Murray; Stevenson, Diane; Mant, David CA; Ford, Alexander C; Macdonald, Thomas M; Bradburn, Mike; Klauza, Claire A; Shone, Angela; Logan, Richard FA; Deeks, Jonathan J; McColl, Kenneth E.L.; Goddard, Andrew F; Stevens, Richard; Sami, Sarned; Haughney, John; Cupples, Margaret E; Morar, Monique; O'Brien, Wendy
Source
The Lancet; November 2022, Vol. 400 Issue: 10363 p1597-1606, 10p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Peptic ulcers in patients receiving aspirin are associated with Helicobacter pyloriinfection. We aimed to investigate whether H pylorieradication would protect against aspirin-associated ulcer bleeding.